Background: Immune thrombocytopenic purpura (ITP) is an immuno-mediated disease
characterized by a decrease in platelet count and, in its more severe forms, by bleeding …

The aim of this survey was to describe drug-induced immune thrombocytopenia (ITP)
reported in the French PharmacoVigilance database (FPVD) and to discuss the drugs …

The most important reasons cited by the opponents of vaccines are concerns about vaccine
safety. Unlike issues such as autism for which no indisputable documentation of direct …

The cause of immune thrombocytopenia (ITP) remains unknown. Studies have suggested
immunizations as possible triggering factors of ITP through molecular mimicry. This case …

BACKGROUND: The etiology of thrombocytopenia during infancy and early childhood may
be different from that of older children, because young children frequently receive vaccines …

Several therapeutic agents can cause thrombocytopenia by either immune-mediated or non-
immune-mediated mechanisms. Non-immune-mediated thrombocytopenia is due to direct …

BACKGROUND: The risk of immune thrombocytopenic purpura (ITP) after childhood
vaccines other than measles-mumps-rubella vaccine (MMR) is unknown. METHODS: Using …

Immune thrombocytopenia (ITP) of childhood (previously known as idiopathic
thrombocytopenic purpura) is characterized by isolated, immunemediated thrombocytopenia …

Background Acute, immune‐mediated thrombocytopenia may be caused by many different
approved drugs as well as by other substances including vaccines, complementary and …

This case–control study investigated immune thrombocytopenic purpura (ITP) risk following
live, inactivated, and simultaneous vaccination, with a focus on infants aged< 2 years. We …